Palliative radiation therapy

Experimental and Clinical Metastasis: A Comprehensive Review

Volumn 9781461436850, Issue , 2013, Pages 351-379

  Cury, Fabio Luis ^a   Shenouda, George ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930813730     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-3685-0_25     Document Type: Chapter

References (108)

1. Aloia TA et al (2006) Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 141:460-466 (discussion 466-467)
2. Ammirati M et al (2010) The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:85-96
3. Andrews DW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665-1672
4. Antonadou D et al (2002a) Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 20:3644-3650
5. Antonadou D et al (2002b) Whole brain radiotherapy alone or in combination with temozolomide for brain metastases. A phase III study. Int J Radiat Oncol Biol Phys 54:93-94
6. Aoyama H et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483-2491
7. Arbit E et al (1995) The treatment of patients with recurrent brain metastases. A retrospective analysis of 109 patients with nonsmall cell lung cancer. Cancer 76:765-773
8. Armstrong CL et al (2000) Radiotherapeutic effects on brain function: double dissociation of memory systems. Neuropsychiatry Neuropsychol Behav Neurol 13:101-111
9. Armstrong CL et al (2002) Late cognitive and radiographic changes related to radiotherapy: initial prospective findings. Neurology 59:40-48
10. Barnes EA et al (2010) Physician expectations of treatment outcomes for patients with brain metastases referred for whole brain radiotherapy. Int J Radiat Oncol Biol Phys 76:187-192
11. Belka C, Budach W, Kortmann RD, Bamberg M(2001)Radiation induced CNStoxicity-molecular and cellular mechanisms. Br J Cancer 85:1233-1239
12. Berk L (1995) Prospective trials for the radiotherapeutic treatment of bone metastases. Am J Hosp Palliat Care 12:24-28
13. Bhatnagar A, Heron DE, Kondziolka D, Lunsford LD, Flickinger JC (2002) Analysis of repeat stereotactic radiosurgery for progressive primary and metastatic CNS tumors. Int J Radiat Oncol Biol Phys 53:527-532
14. Bindal RK, Sawaya R, Leavens ME, Lee JJ (1993) Surgical treatment of multiple brain metastases. J Neurosurg 79:210-216
15. Borgelt B et al (1981) Ultra-rapid high dose irradiation schedules for the palliation of brain metas-tases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 7:1633-1638
16. Burt M, Wronski M, Arbit E, Galicich JH (1992) Resection of brain metastases from non-small-cell lung carcinoma. Results of therapy. Memorial Sloan-Kettering Cancer Center Thoracic Surgical Staff. J Thorac Cardiovasc Surg 103:399-410 (discussion 410-411)
17. Chatani M, Teshima T, Hata K, Inoue T (1986) Prognostic factors in patients with brain metastases from lung carcinoma. Strahlenther Onkol 162:157-161
18. Chougule PB et al (2000) Randomized treatment of brain metastasis with gamma knife radiosurgery, whole brain radiotherapy or both. Int J Radiat Oncol Biol Phys 48:114
19. Chow E, Harris K, Fan G, Tsao M, Sze WM (2007) Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 25:1423-1436
20. Clezardin P, Teti A (2007) Bone metastasis: pathogenesis and therapeutic implications. Clin Exp Metastasis 24:599-608
21. Coleman RE (2001) Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27:165-176
22. Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12:6243s-6249s
23. Coleman RE, Rubens RD (1987) The clinical course of bone metastases from breast cancer. Br J Cancer 55:61-66
24. Cook GJ, Houston S, Rubens R, Maisey MN, Fogelman I (1998) Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 16:3375-3379
25. Dunlap NE et al (2008) Chest wall volume receiving more than 30 Gy predicts risk of severe pain and/or rib fracture following lung SBRT. Int J Radiat Oncol Biol Phys 72:S36
26. Dunlap NE et al (2010) Chest wall volume receiving > 30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 76:796-801
27. Elte JW, Bijvoet OL, Cleton FJ, van Oosterom AT, Sleeboom HP (1986) Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and bisphosphonate treatment. Eur J Cancer Clin Oncol 22:493-500
28. Emami B et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109-122
29. Even-Sapir E et al (2006) The detection of bone metastasesinpatients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single-and multi-field-of-view SPECT, 18F-Fluoride PET, and 18F-Fluoride PET/CT. J Nucl Med 47:287-297
30. Fakiris AJ et al (2009) Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 75:677-682
31. Falkson G, Gelman RS, Leone L, Falkson CI (1990) Survival of premenopausal women with metastatic breast cancer. Long-term follow-up of Eastern Cooperative Group and Cancer and Leukemia Group B studies. Cancer 66:1621-1629
32. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309-318 (discussion 318-321)
33. Fukumoto S-i et al (2002) Small-volume image-guided radiotherapy using hypofractionated, copla-nar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas. Cancer 95:1546-1553
34. Gaspar L et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745-751
35. Gaspar LE et al (2010) The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:17-32
36. Gerszten PC, Burton SA, Ozhasoglu C, Welch WC (2007) Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976) 32:193-199
37. Glantz MJ et al (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54:1886-1893
38. Greenberg PA et al (1996) Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol 14:2197-2205
39. Guerrieri M et al (2004) A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung. Lung Cancer 46:107-111
40. Halfdanarson TR, Hogan WJ, Moynihan TJ (2006) Oncologic emergencies: diagnosis and treatment. Mayo Clin Proc 81:835-848
41. Harrington KD (1997) Orthopedic surgical management of skeletal complications of malignancy. Cancer 80:1614-1627
42. Hartsell WF et al (2005) Randomized trial of short-versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 97:798-804
43. Hazuka MB, Kinzie JJ (1988) Brain metastases: results and effects of re-irradiation. Int J Radiat Oncol Biol Phys 15:433-437
44. Hazuka MB et al (1993) Multiple brain metastases are associated with poor survival in patients treated with surgery and radiotherapy. J Clin Oncol 11:369-373
45. Herfarth KK et al (2001) Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 19:164-170
46. Herfarth KK et al (2003) Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys 57:444-451
47. Hird A et al (2009) Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three canadian cancer centers. Int J Radiat Oncol Biol Phys 75:193-197
48. Hof H, Hoess A, Oetzel D, Debus J, Herfarth K (2007) Stereotactic single-dose radiotherapy of lung metastases. Strahlenther Onkol 183:673-678
49. Ibrahim T et al (2010) Pathogenesis of osteoblastic bone metastases from prostate cancer. Cancer 116:1406-1418
50. Jackson Sai-Yiu W, Rebecca W, Mary J, Andrea B, Timothy W (2003) Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55:594-605
51. Jelinek JS et al (2002) Diagnosis of primary bone tumors with image-guided percutaneous biopsy: experience with 110 tumors. Radiology 223:731-737
52. Jemal A et al (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10-30
53. Käkönen S-M, Mundy GR (2003) Mechanisms of osteolytic bone metastases in breast carcinoma. Cancer 97:834-839
54. Klein M et al (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360:1361-1368
55. Komarnicky LT et al (1991) A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys 20:53-58
56. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC(1999) Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45:427-434
57. Koswig S, Budach V (1999) Remineralization and pain relief in bone metastases after after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study. Strahlenther Onkol 175:500-508
58. Koswig S, Buchali A, Bohmer D, Schlenger L, Budach V (1999) Palliative radiotherapy of bone metastases. A retrospective analysis of 176 patients. Strahlenther Onkol 175:509-514
59. Kurtz JM, Gelber R, Brady LW, Carella RJ, Cooper JS (1981) The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 7:891-895
60. Lee SW et al (2003) Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer 40:309-315
61. Li KC, Poon PY (1988) Sensitivity and specificity of MRI in detecting malignant spinal cord compression and in distinguishing malignant from benign compression fractures of vertebrae. Magn Reson Imaging 6:547-556
62. Lippitz BE et al (2004) Gamma knife radiosurgery for patients with multiple cerebral metastases. Acta Neurochir Suppl 91:79-87
63. McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD(2005) Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 63:1010-1015
64. Mehta M et al (1997)A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases. Int J Radiat Oncol Biol Phys 39:445-454
65. Mehta MP et al (1992) Defining the role of radiosurgery in the management of brain metastases. Int J Radiat Oncol Biol Phys 24:619-625
66. Mehta MP et al (2003) Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 21:2529-2536
67. Mercadante S (1997) Malignant bone pain: pathophysiology and treatment. Pain 69:1-18
68. Meyers CA et al (2004) Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22:157-165
69. Milano MT et al (2008) A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer 112:650-658
70. Mintz AH et al (1996)A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 78:1470-1476
71. Monje ML, Palmer T (2003) Radiation injury and neurogenesis. Curr Opin Neurol 16:129-134
72. Monje ML, Mizumatsu S, Fike JR, Palmer TD (2002) Irradiation induces neural precursor-cell dysfunction. Nat Med 8:955-962
73. Nagata Y et al (2005) Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63:1427-1431
74. Nieder C et al (1999) Late radiation toxicity after whole brain radiotherapy: the influence of antiepileptic drugs. Am J Clin Oncol 22:573-579
75. Nielsen OS, Bentzen SM, Sandberg E, Gadeberg CC, Timothy AR (1998) Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol 47:233-240
76. Patchell RA, Posner JB(1985) Neurologic complications of systemic cancer. Neurol Clin 3:729-750
77. Patchell RA et al (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494-500
78. Patchell RA et al (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280:1485-1489
79. Patchell RA et al (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366:643-648
80. Pradier O, Bouchekoua M, Albargach N, Muller M, Malhaire JP (2008) Radiothérapie des méta-stases osseuses: quel est lemeilleur schéma de radiothérapie? Cancer/Radiothérapie 12:837-841
81. Rades D et al (2006) Defining the appropriate radiotherapy regimen for metastatic spinal cord compression in non-small cell lung cancer patients. Eur J Cancer 42:1052-1056
82. Rades D et al (2005) Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol 23:3366-3375
83. Ratanatharathorn V, Powers WE, Moss WT, Perez CA (1999) Bone metastasis: review and critical analysis of random allocation trials of local field treatment. Int J Radiat Oncol Biol Phys 44:1-18
84. Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350:1655-1664
85. Roos DE et al (2005) Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol 75:54-63
86. Rusthoven KE et al (2009a) Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27:1572-1578
87. Rusthoven KE et al (2009b) Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 27:1579-1584
88. Saarto T, Janes R, Tenhunen M, Kouri M (2002) Palliative radiotherapy in the treatment of skeletal metastases. Eur J Pain 6:323-330
89. Sawaya R, Ligon BL, Bindal RK (1994) Management of metastatic brain tumors. Ann Surg Oncol 1:169-178
90. Shah SA et al (2007) Survival after liver resection for metastatic colorectal carcinoma in a large population. J Am Coll Surg 205:676-683
91. Simonova G, Liscak R, Novotny J Jr, Novotny J (2000) Solitary brain metastases treated with the Leksell gamma knife: prognostic factors for patients. Radiother Oncol 57:207-213
92. Steenland Eet al (1999) The effect ofasingle fraction compared to multiple fractions onpainful bone metastases: a global analysis of the Dutch bone metastasis study. Radiother Oncol 52:101-109
93. Suh JH et al (2006) Phase III study of Efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases. J Clin Oncol 24:106-114
94. Sundaresan N, Sachdev V, Di Giacinto G, Hughes J (1988) Reoperation for brain metastases. J Clin Oncol 6:1625-1629
95. Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD (2003) Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy-A systematic review ofrandomised trials. Clin Oncol 15:345-352
96. Sze WM, Shelley M, Held I, Mason M (2004) Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy-A systematic review of the randomised trials. Cochrane Database System Review CD004721
97. Timmerman R et al (2006) Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24:4833-4839
98. Tong D, Gillick L, Hendrickson FR (1982) The palliation of symptomatic osseous metastases: final results of the study by the radiation therapy oncology group. Cancer 50:893-899
99. Townsend PW, Smalley SR, Cozad SC, Rosenthal HG, Hassanein RE (1995) Role of postoperative radiation therapy after stabilization of fractures caused by metastatic disease. Int J Radiat Oncol Biol Phys 31:43-49
100. Tracey ES et al (2005) A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 62:1371-1378
101. Ushio Y et al (1991) Chemotherapy of brain metastases from lung carcinoma: a controlled randomized study. Neurosurgery 28:201-205
102. Vecht CJ et al (1993) Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 33:583-590
103. Verger E et al (2005) Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. Int J Radiat Oncol Biol Phys 61:185-191
104. Wen PY, Black PM, Loeffler JS (ed) (2001) Treatment of metastatic cancer. Lippincott Williams & Wilkins, Philadelphia
105. William WW, Steven ES, Timothy ES, Edward GS (1996) Analysis of outcome in patients reirradiated for brain metastases. Int J Radiat Oncol Biol Phys 34:585-590
106. Wulf J et al (2004) Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 60:186-196
107. Xia T et al (2006) Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 66:117-125
108. Yarnold JR (1999) 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up on behalf of the bone pain trial working party. Radiother Oncol 52:111-121